Pfizer

  • Xalkori 2015 report

    Xalkori 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 22 Pages The 5 Key Questions Addressed by this...

  • Xeljanz 2015 report

    Xeljanz 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 20 Pages The 5 Key Questions Addressed by this...

  • Xyntha Solofuse 2015 report

    Xyntha Solofuse 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 27 Pages The 5 Key Questions Addressed by...

  • Zyvox 2015 report

    Zyvox 2015 U.S. PROMOTIONAL AUDIT REPORT Published July 2016 • 32 Pages The 5 Key Questions Addressed by this...

  • Bosulif 2014 report

    Bosulif 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Celebrex 2014 report

    Celebrex 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 29 Pages The 5 Key Questions Addressed by this...

  • Chantix 2014 report

    Chantix 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this Report:...

  • Duavee 2014 report

    Duavee 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Elelyso 2014 report

    Elelyso 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 33 Pages The 5 Key Questions Addressed by this...

  • Eliquis 2014 report

    Eliquis 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 26 Pages The 5 Key Questions Addressed by this...

  • Estring 2014 report

    Estring 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 22 Pages The 5 Key Questions Addressed by this...

  • Flector Patch 2014 report

    Flector Patch 2014 U.S. PROMOTIONAL AUDIT REPORT Published July 2015 • 31 Pages The 5 Key Questions Addressed by...